clotrimazole has been researched along with Cancer of Endometrium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mhawech-Fauceglia, P | 1 |
Wang, D | 1 |
Kesterson, J | 1 |
Beck, A | 1 |
de Mesy Bentley, KL | 1 |
Shroff, S | 1 |
Syriac, S | 1 |
Frederick, P | 1 |
Liu, S | 1 |
Odunsi, K | 1 |
Wang, ZH | 2 |
Shen, B | 1 |
Yao, HL | 1 |
Jia, YC | 1 |
Ren, J | 1 |
Feng, YJ | 2 |
Wang, YZ | 1 |
Su, M | 1 |
Yi, XF | 1 |
3 other studies available for clotrimazole and Cancer of Endometrium
Article | Year |
---|---|
Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology.
Topics: 14-alpha Demethylase Inhibitors; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Survival; Clot | 2011 |
Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
Topics: Animals; Cell Cycle; Cell Proliferation; Charybdotoxin; Clotrimazole; Endometrial Neoplasms; Female; | 2007 |
[Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
Topics: Adult; Aged; Cell Line, Tumor; Cell Proliferation; Clotrimazole; Dose-Response Relationship, Drug; E | 2007 |